The latest clinical trial results from Eli Lilly show the drug manufacturer's once-weekly insulin injection is just as ...

Implanting a pouch of stem-cell-derived pancreas cells under the skin of type 1 diabetics has enabled them to live without ...

New research published in New England Journal of Medicine and presented at this year's Annual Meeting of the European ...

For people with type 1 diabetes, management burden including suboptimal insulin preparations remains a major barrier to ...

People with type 1 or type 2 diabetes could soon benefit from weekly insulin injections after new research showed they are as effective at controlling blood sugar levels as daily jabs of long-acting ...

Eli Lilly and Company (NYSE: LLY) today announced detailed results from the QWINT-5 phase 3 trial evaluating once-weekly ...

New research published in NEJM and presented at this year's Annual Meeting of the European Association for the Study of ...

Sometimes a combination therapy involving insulin injections and non-insulin oral medications are used. Tal said people with diabetes need to be vigilant in managing their condition.

The late-stage clinical trial results showed that Eli Lilly’s once-weekly insulin efsitora matched daily injections for ...

Data from the two Phase III trials showed that once-weekly insulin efsitora induced HbA1C reductions similar to daily insulin ...

Clinical trials of a new, once-a-week insulin have shown that it controls blood sugar as well as daily injections of an ...